Evolución temporal de la terapia antirretroviral (2017-2021): análisis de la modificación del tratamiento y su impacto económico / Temporal evolution of antiretroviral therapy (2017-2021): analysis of treatment change and its economic impact

Objetivos. Analizar las modificaciones de la terapia antirre troviral (TAR) y su impacto económico en la práctica clínica diaria. Material y métodos. Estudio observacional, retrospectivo de los pacientes que iniciaron TAR entre 01/2017-12/2021 (se guimiento hasta 12/2022). Variables recogidas: TAR, duración, motivo del cambio y costes del tratamiento. Resultados. 280 pacientes iniciaron TAR. La mediana de durabilidad de la 1ª línea fue: 19,9 meses en 2017 (IC95% 13,9-25,9), 12,2 meses en 2018 (IC95% 4,7-19,7), 27,4 meses en 2019 (IC95% 6,8-48,1) y no se alcanzó la mediana para los años 2020 y 2021 (p p<0,001). De un total de 541 líneas prescri tas, la triple terapia con inhibidores de la proteasa se modificó en el 63,8% (81/127), seguido de los inhibidores de la integrasa 52,1% (159/305), mientras que, la terapia dual (DTG/3TC) solo en el 8,3% (7/84). De un total de 261 modificaciones, la simpli ficación/optimización 47,5% (124/261) fue el principal motivo, seguido de efectos adversos 21,8% (57/261), siendo el 2017 el único año donde ambos motivos se encontraban al mismo nivel. El impacto económico de los cambios supusieron una re ducción del coste medio de 34,0€ [-391,4 a +431,4] al mes/ paciente. El año 2019 es el único año donde estos cambios se asociaron con un incremento del coste adicional medio (23,4€ [-358,3 a +431,4]). Conclusiones. Dejando atrás el fracaso virológico, la sim plificación a regímenes de un solo comprimido y de mayor tolerancia han marcado la nueva la era TAR. Con un impacto económico que, a pesar del punto de inflexión del 2019, refleja una reducción progresiva de costes mantenida en el tiempo (AU)

Objectives. To analyze the modifications of antiretrovi ral therapy (ART) and their economic impact on daily clinical practice. Material and methods. Observational, retrospective study of patients who started ART between 01/2017-12/2021 (follow-up until 12/2022). Variables collected: prescribed ART, duration, the reason for the change, and treatment costs. Results. A total of 280 patients initiated ART therapy. The median durability of 1st line was: 19.9 months in 2017 (95%CI 13.9-25.9), 12.2 months in 2018 (95%CI 4.7-19.7), 27.4 months in 2019 (95%CI 6.8-48.1) and the median was not reached for the years 2020 and 2021 (p<0.001). Triple therapy with protease inhibitors was changed in 63.8% (81/127) of cases, followed by integrase inhibitors 52.1% (159/305), while dual therapy (DTG/3TC) only in 8.3% (7/84). The main cause of dis continuation was simplification/optimization 47.5% (124/261), followed by adverse effects 21.8% (57/261), with 2017 being the only year where simplification/optimization was at the same level as adverse effects. The economic impact of ART changes resulted in an average cost reduction of 34.0€ [-391.4 to +431.4] per month per patient. The year 2019 stands out as the only year where these changes were associated with an increase in mean additional cost (23.4€ [-358.3 to +431.4]). Conclusions. Optimization/simplification accounts for almost half of the reasons for TAR change, with an econom ic impact that, despite the inflection point of 2019, each year manages to exceed the previous one, achieving a progressive cost reduction maintained over time (AU)

Percepción del impacto económico en pacientes con cáncer en un hospital de tercer nivel, La Paz - Bolivia: un estudio exploratorio cualitativo / Perception of the economic impact in patients diagnosed with cancer in a third level hospital, La Paz - Bolivia: a qualitative exploratory study

Los pacientes con cáncer experimentan además del impacto de la enfermedad, el impacto económico, y este es más evidente en los pacientes con escasos recursos económicos, los motivos son multifactoriales. OBJETIVO: describir la percepción sobre el impacto económico en los pacientes bolivianos con cáncer en el Hospital de Clínicas Universitario- La Paz. MÉTODOS: el diseño es cualitativo exploratorio, muestreo por bola de nieve, se realizaron entrevistas a profundidad dirigidas a pacientes con cáncer del hospital de Clínicas Universitario de La Paz- Bolivia entre diciembre de 2018 a febrero de 2019. RESULTADOS: se entrevistaron a 11 pacientes y 9 familiares. Se han identificado el impacto de los gastos en los pacientes con cáncer en las siguientes categorías: Ahorros y deudas, vivienda, trabajo, familia, tratamiento, esfera psicológica, gastos a futuro, y en el cuidado de otros enfermos en la casa. Las percepciones son variables, algunos pacientes muestran mayor preocupación por su economía que por su enfermedad, relatan además el cambio que significó en su económica recibir el diagnóstico de cáncer en distintas áreas. CONCLUSIÓN: se ha encontrado, en el presente trabajo, que la percepción del impacto económico para los pacientes con cáncer es multidimensional. Se ha evidenciado además, que el impacto depende del estadio de la enfermedad y del contexto social que vive el paciente, siendo este variable y dando como resultado necesidades de acompañamiento variable por parte de los equipos oncológicos

Cancer patients experience, is about disease´s and economic impact, and this impact is more evident in patients with limited economic resources in low-income countries, the reasons are multifactorial. OBJECTIVE: describe the perception of the economic impact on Bolivian patients with cancer at the Hospital de Clínicas Universitario-La Paz. METHODS: the design is qualitative and exploratory, sampling was by snowball, in-depth interviews were conducted at cancer patients at the Clínicas Universitario de La Paz hospital - Bolivia between December 2018 and February 2019. RESULTS: 11 patients and 9 family members were interviewed. The impact of expenses on cancer patients has been identified in the following categories: Savings and debts, housing, work, family, treatment, psychological sphere, future expenses, and caring for other patients at home. Perceptions are variable, some patients show more significant concern about their finances than about their illness, and they also report the change that receiving the diagnosis of cancer meant in their finances in different areas. CONCLUSION: in this investigation, the perception of economic impact on cancer patients is multidimensional. It has also been shown that the impact depends on the stage of the disease, and the social context in which the patient lives, this being variable and resulting in variable support needs from the oncology teams

Estimating the economic impact of gender-based violence on women survivors: A comparative study of support program interventions in Makueni and Naivasha, Kenya.

OBJECTIVE: To estimate the economic cost of GBV from the perspective of a women survivor who sought help from two identified programs (Makueni GBVRC and Life Bloom Services International [LBSI]). DESIGN: A mixed method research design combining qualitative and quantitative approaches. SITE: Makueni GBVRC in Makueni County, overseen by the Makueni County government, and LBSI in Naivasha, Nakuru County, a non-profit organization devoted to serving local communities. PARTICIPANTS: Study participants include women survivors of GBV, aged 18 and above, actively seeking services at Makueni GBVRC and LBSI. INTERVENTIONS: The study adopts a qualitative approach to delve into the intricate economic costs of GBV on survivors. Additionally, quantitative data analysis employs an accounting model to ascertain the financial implications. MAIN MEASUREMENTS: The costs analyses were done from the perspective of the women survivors. An accounting model was utilized to evaluate the cost of GBV on selected survivors. Furthermore, the research explores the enduring consequences for survivors, including psychological trauma and susceptibility to stress-related diseases. RESULTS: The findings reveal substantial economic costs linked to GBV, adversely affecting survivors, their children, and society at large. These costs encompass direct expenditures on medical care, legal representation, and counseling, as well as indirect costs, such as lost productivity. CONCLUSIONS: Beyond immediate and indirect costs, the study underscores the existence of opportunity costs-what survivors and affected children could attain in the absence of GBV.

Impacto económico del uso de patiromer en enfermedad renal crónica o insuficiencia cardíaca para el tratamiento de la hiperpotasemia crónica en España / Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

Introducción La hiperpotasemia crónica tiene consecuencias negativas a medio y largo plazo, condicionando generalmente la suspensión de fármacos nefro y cardioprotectores, en pacientes con enfermedad renal crónica (ERC) e insuficiencia cardíaca (IC), como son los inhibidores del sistema renina-angiotensina-aldosterona. Existe una alternativa a la suspensión o reducción de dosis de estos tratamientos y es la administración de quelantes del potasio. El objetivo de este estudio es estimar el impacto económico que supondría el uso de patiromer en pacientes con ERC o IC e hiperpotasemia en España. Material y métodos Se ha estimado el impacto económico anual del uso de patiromer desde la perspectiva de la sociedad española, comparando 2 escenarios: pacientes con ERC o IC e hiperpotasemia tratada con patiromer y sin patiromer. Los costes se han actualizado a euros de 2020, utilizando el índice de precios de consumo de Sanidad. Se han considerado los costes directos sanitarios relacionados con el uso de recursos (el tratamiento con inhibidores del sistema renina-angiotensina-aldosterona, la progresión de la ERC, los eventos cardiovasculares y la hospitalización por hiperpotasemia), los costes directos no sanitarios (cuidados informales: costes derivados del tiempo de dedicación por parte de los familiares del paciente), los costes indirectos (pérdidas de productividad laboral), así como un coste intangible (por mortalidad prematura). Se realizó un análisis de sensibilidad determinístico para validar la consistencia de los resultados del estudio. Resultados El coste medio anual por paciente en el escenario sin patiromer es de 9.834,09 € y 10.739,37 € en ERC e IC, respectivamente. El uso de patiromer supondría un ahorro de costes superior al 30% en ambas enfermedades. En el caso de la ERC, el mayor ahorro procede del retraso de la progresión de la ERC (AU)

Introduction Chronic hyperkalemia has negative consequences in the medium and long term, and determines the suspension of nephro and cardioprotective drugs, such as renin–angiotensin–aldosterone system inhibitors (RAASi). There is an alternative to the suspension or dose reduction of these treatments: the administration of potassium chelators. The aim of this study is to estimate the economic impact of the use of patiromer in patients with chronic kidney disease (CKD) or heart failure (HF) and hyperkalemia in Spain. Materials and method The annual economic impact of the use of patiromer has been estimated from the perspective of the Spanish society. Two scenarios were compared: patients with CKD or HF and hyperkalemia treated with and without patiromer. The costs have been updated to 2020 euros, using the Health Consumer Price Index. Direct healthcare costs related to the use of resources (treatment with RAASi, CKD progression, cardiovascular events and hospitalization due to hyperkalemia), direct non-healthcare costs (informal care: costs derived from time dedicated by patient's relatives), the indirect costs (productivity loss), as well as an intangible cost (due to premature mortality) were considered. A deterministic sensitivity analysis was performed to validate the robustness of the study results. Results The mean annual cost per patient in the scenario without patiromer is €9834.09 and €10,739.37 in CKD and HF, respectively. The use of patiromer would lead to cost savings of over 30% in both diseases. The greatest savings in CKD come from the delay in the progression of CKD. While in the case of HF, 80.1% of these savings come from premature mortality reduction. The sensitivity analyses carried out show the robustness of the results, obtaining savings in all cases (AU)

Flebite associada ao cateter venoso periférico em cardiologia: incidência, fatores de risco e custos associados / Phlebitis associated with peripheral venous catheter in cardiology: incidence, risk factors and associated costs

Objetivo: Determinar a incidência de flebite, fatores de risco associados e custos diretos de tratamento. Métodos: Estudo descritivo, correlacional, com análise de custo direto. Utilizaram-se dados da documentação dos enfermeiros entre janeiro 2019 e agosto 2021. Resultados: Incluíram-se 2.374 pessoas com cateter venoso periférico, com internamento na cardiologia. A incidência de flebite foi de 12,38%, das quais 78,23% eram de grau 1 de severidade. Verificou-se associação estatística entre o desenvolvimento de flebite e a administração de amiodarona endovenosa, dias de hospitalização e serviço de internamento. Estimaram-se 1662€ de custos adicionais ao tratamento da flebite, em material clínico e horas de cuidados de enfermagem. Conclusão: Os cuidados de enfermagem são eficazes na identificação precoce e tratamento da flebite, promovendo redução de custos adicionais e garantindo melhores cuidados e ganhos em saúde.

Objective: This study aimed to identify the incidence rate of phlebitis, associated risk factors and treatment direct costs. Methods: Descriptive, correlational study with direct cost analisys. Data from the nurses' clinical records between January 2019 and August 2021 were used. Results: Included 2,374 files of people with peripheral venous catheter who were admitted to Cardiology. The phlebitis incidence rate was 12.38% and regarding severity 78.23% were grade 1. The phlebitits was significantly related with intravenous amiodarone administration, length of stay and physical department. This represents €1662 of additional treatment costs, in clinical supplies and nursing time. Conclusion: Nursing care is effective in the early identification and treatment of phlebitis, reducing costs and improve clinical and economic outcomes.

El impacto económico de los campeonatos de Europa de bádminton elite y senior / The economic impact of elite and senior badminton European championships

El presente estudio analiza, aplicando idéntica metodología (Análisis Coste Beneficio), el impacto económico de dos eventos deportivos internacionales (campeonato de Europa élite de Huelva y sénior de Guadalajara) de la misma modalidad deportiva (bádminton) celebrados el mismo año (2018)yen el mismo país(España) con el objetivo de identificar si los factores determinantes pueden influir en el impacto económico y en el impacto turístico de un territorio. La recogida de datos se realizó mediante una entrevista al organizador y un cuestionario (3 dimensiones, 12 preguntas) durante los días de los campeonatos (437 cuestionarios en Huelva y 162 cuestionarios en Guadalajara).Las principales conclusiones fueron: 1) sobre el impacto económico, la categoría “tipología de evento” (elite o sénior) está relacionado con el subgrupo y número de participantes siendo el factor más determinante de gasto; y 2) en relación con el impacto turístico, se puede considerar que los eventos deportivos de élite son una buena estrategia para atraer espectadores mientras que los eventos seniors lo son para atraer competidores. (AU)

The current study analyzed, with identical methodologies (Cost-Benefit Analysis), the economic impact of two international sporting events (European Championships Elite and Senior) of the same sport discipline (Badminton), organized during the same year (2018), in the same country (Spain), aiming at identifying how determining factors affect the economic impact.Data was collected from the organization and via surveys (3 dimension, 12 questions) during the days of the event (437 surveys in Huelva and 162 surveys in Guadalajara).The main conclusions are: (1) for the economic impact, is that the variable “event category” (Elite or Senior) determined the typology and number of participants which, were the main determining factors of expenditure; and (2) for the tourism impact, we were able to conclude that the sporting event is a powerful tool to attract spectators in elite events and competitors in senior events. (AU)

Economic costs of protecting islands from invasive alien species.

Biological invasions represent a key threat to insular systems and have pronounced impacts across environments and economies. The ecological impacts have received substantial focus, but the socioeconomic impacts are poorly synthesized across spatial and temporal scales. We used the InvaCost database, the most comprehensive assessment of published economic costs of invasive species, to assess economic impacts on islands worldwide. We analyzed socioeconomic costs across differing expenditure types and examined temporal trends across islands that differ in their political geography-island nation states, overseas territories, and islands of continental countries. Over US$36 billion in total costs (including damages and management) has occurred on islands from 1965 to 2020 due to invasive species' impacts. Nation states incurred the greatest total and management costs, and islands of continental countries incurred costs of similar magnitude, both far higher than those in overseas territories. Damage-loss costs were significantly lower, but with qualitatively similar patterns across differing political geographies. The predominance of management spending differs from the pattern found for most countries examined and suggests important knowledge gaps in the extent of many damage-related socioeconomic impacts. Nation states spent the greatest proportion of their gross domestic products countering these costs, at least 1 order of magnitude higher than other locations. Most costs were borne by authorities and stakeholders, demonstrating the key role of governmental and nongovernmental bodies in addressing island invasions. Temporal trends revealed cost increases across all island types, potentially reflecting efforts to tackle invasive species at larger, more socially complex scales. Nevertheless, the already high total economic costs of island invasions substantiate the role of biosecurity in reducing and preventing invasive species arrivals to reduce strains on limited financial resources and avoid threats to sustainable development goals.

Costos económicos de proteger a las islas de las especies invasoras Resumen Las invasiones biológicas representan una amenaza importante para los sistemas insulares, además de tener impactos pronunciados en el ambiente y en la economía. Los impactos ecológicos han recibido atención sustancial, mientras que los impactos socioeconómicos se encuentran pobremente sintetizados en las escalas temporales y espaciales. Usamos la base de datos InvaCost, el análisis más completo de los costos económicos de las especies invasoras, para evaluar los impactos económicos sobre las islas a nivel mundial. Analizamos los costos socioeconómicos en varios tipos de gastos y examinamos las tendencias temporales en las islas que difieren en su geografía política - islas estado-nación, territorios ultramarinos e islas de países continentales. En las islas han ocurrido gastos de más de $36 mil millones de dólares entre 1965 y 2020 debido a los impactos de las especies invasoras. Las islas estado-nación produjeron los mayores costos de manejo y el mayor total, mientras que las islas de los países continentales produjeron costos de una magnitud similar, ambas con gastos mucho más elevados que los de los territorios ultramarinos. Los costos de las pérdidas por daños fueron significativamente más bajas, aunque con patrones cualitativamente similares entre las diferentes geografías políticas. El predominio del gasto en el manejo difiere del patrón hallado en la mayoría de los países analizados y sugiere que hay vacíos importantes en el conocimiento del alcance de muchos de los impactos socioeconómicos relacionados con los daños. Las islas estado-nación gastaron la mayor proporción de su producto interno bruto en contrarrestar estos costos, al menos una orden de magnitud mayor que las otras localidades. La mayoría de los costos fueron asumidos por las autoridades y los accionistas, lo que demuestra el papel clave que tienen los organismos gubernamentales y no gubernamentales en cómo se atienden las invasiones insulares. Las tendencias temporales revelaron incrementos en el costo en todos los tipos de islas, lo que potencialmente refleja los esfuerzos por combatir a las especies invasoras a escalas más grandes y socialmente más complejas. Aun así, el elevado costo económico total de las invasiones insulares fundamenta la función que tiene la bioseguridad en la reducción y prevención de la llegada de especies invasoras para reducir presiones sobre los recursos financieros limitados y evitar amenazas para las metas de desarrollo sustentable.

Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain.

INTRODUCTION: Chronic hyperkalemia has negative consequences in the medium and long term, and determines the suspension of nephro and cardioprotective drugs, such as renin-angiotensin-aldosterone system inhibitors (RAASi). There is an alternative to the suspension or dose reduction of these treatments: the administration of potassium chelators. The aim of this study is to estimate the economic impact of the use of patiromer in patients with chronic kidney disease (CKD) or heart failure (HF) and hyperkalemia in Spain. MATERIALS AND METHOD: The annual economic impact of the use of patiromer has been estimated from the perspective of the Spanish society. Two scenarios were compared: patients with CKD or HF and hyperkalemia treated with and without patiromer. The costs have been updated to 2020 euros, using the Health Consumer Price Index. Direct healthcare costs related to the use of resources (treatment with RAASi, CKD progression, cardiovascular events and hospitalization due to hyperkalemia), direct non-healthcare costs (informal care: costs derived from time dedicated by patient's relatives), the indirect costs (productivity loss), as well as an intangible cost (due to premature mortality) were considered. A deterministic sensitivity analysis was performed to validate the robustness of the study results. RESULTS: The mean annual cost per patient in the scenario without patiromer is €9,834.09 and €10,739.37 in CKD and HF, respectively. The use of patiromer would lead to cost savings of over 30% in both diseases. The greatest savings in CKD come from the delay in the progression of CKD. While in the case of HF, 80.1% of these savings come from premature mortality reduction. The sensitivity analyses carried out show the robustness of the results, obtaining savings in all cases. CONCLUSIONS: The incorporation of patiromer allows better control of hyperkalemia and, as a consequence, maintain treatment with RAASi in patients with CKD or HF. This would generate a 32% of annual savings in Spain (€3,127 in CKD; €3,466 in HF). The results support the positive contribution of patiromer to health cost in patients with only CKD or in patients with only HF.

Economic impact of periprosthetic hip fractures / Impacto económico de las fracturas periprotésicas de cadera

Introduction: Hip replacement is one of the most successful operations in orthopaedic surgery. Periprosthetic hip fractures (PPHF) have very serious consequences for the patient, and they also entail a very important economic impact on healthcare systems. The aim of the study was to provide the first detailed cost analysis of PPHF in a traumatology and orthopaedics service in a third level hospital in Spain. Methods: The study included all patients admitted between 2009 and 2019 with a diagnosis of “PPHF”. We assessed hospital stay cost, total cost of the operating theatre, cost of the implants used, analyses, consultations with other specialists, rehabilitation sessions, radiological tests, microbiology, blood transfusions and other surgical operations during the same admission. Results: 78 patients were included in the study, 49 women and 29 men, with a mean age of 78.74 years (R 45–92). 69 patients received surgical treatment, 75% had open reduction and internal fixation (ORIF), and 25% had revision surgery. The total cost was €1,139,650.17. The average cost was €14,610.90. Significantly higher costs were incurred for revision compared to ORIF treatments, admissions that lasted more than 30 days, and patients who required more than one operation during admission. The most costly factors were the hospital stay (46%), the cost of the surgery itself (35%), and the implants (24%). Conclusions: Revision arthroplasty versus ORIF treatment, admissions lasting more than 30 days, and patients requiring more than one operation on admission incurred significantly higher costs. The average cost, from a hospital perspective, generated by a PPHF was €14,610.90. The most costly factors were, in descending order, the hospital stay, the cost of the surgery itself, and the implants. It is necessary to establish protocols and updated therapeutic algorithms in the perioperative management of PPHF in order to reduce both morbidity rates and associated costs.(AU)

Introducción: La artroplastia de cadera es una de las operaciones con mejores resultados en cirugía ortopédica. Las fracturas periprotésicas de cadera (FPPC) tienen consecuencias muy graves para el paciente y además suponen un impacto económico muy importante para los sistemas sanitarios. El objetivo del estudio es realizar el primer análisis detallado de los costes de las FPPC en un Servicio de Cirugía Ortopédica y Traumatología en un hospital universitario de tercer nivel en España. Métodos: El estudio incluyó a todos los pacientes ingresados entre 2009 y 2019 con el diagnóstico de «FPPC». Se evaluaron el coste de la estancia hospitalaria, el coste total del quirófano, el coste de los implantes utilizados, los análisis de sangre, las consultas con otros especialistas, las sesiones de rehabilitación, las pruebas radiológicas, la microbiología, las transfusiones de sangre y otras intervenciones quirúrgicas durante el mismo ingreso. Resultados: Se incluyó a un total de 78 pacientes, 49 mujeres y 29 hombres, con una edad media de 78,74 años (R 45-92); 69 pacientes recibieron tratamiento quirúrgico, el 75% se sometió a reducción abierta y fijación interna (RAFI) y el 25% a revisión protésica. El coste total fue de 1.139.650,17 €. El coste medio fue de 14.610,90 €. Los costes fueron significativamente más elevados en la revisión protésica que en la RAFI, en los ingresos que duraron más de 30 días y en los pacientes que requirieron más de una intervención quirúrgica durante el ingreso. Los factores que más influyeron en el coste fueron la estancia hospitalaria (46%), el coste de la intervención quirúrgica (35%) y el de los implantes (24%). Conclusiones: La cirugía de revisión protésica frente a RAFI, los ingresos de más de 30 días y los pacientes que requirieron más de una intervención quirúrgica durante el ingreso supusieron costes significativamente mayores. El coste medio, desde el punto de vista hospitalario, generado por una FPPC fue de 14.610,90 €.(AU)

[Artículo traducido] Impacto económico de las fracturas periprotésicas de cadera / Economic impact of periprosthetic hip fractures

Introduction: Hip replacement is one of the most successful operations in orthopaedic surgery. Periprosthetic hip fractures (PPHF) have very serious consequences for the patient, and they also entail a very important economic impact on healthcare systems. The aim of the study was to provide the first detailed cost analysis of PPHF in a traumatology and orthopaedics service in a third level hospital in Spain. Methods: The study included all patients admitted between 2009 and 2019 with a diagnosis of “PPHF”. We assessed hospital stay cost, total cost of the operating theatre, cost of the implants used, analyses, consultations with other specialists, rehabilitation sessions, radiological tests, microbiology, blood transfusions and other surgical operations during the same admission. Results: 78 patients were included in the study, 49 women and 29 men, with a mean age of 78.74 years (R 45–92). 69 patients received surgical treatment, 75% had open reduction and internal fixation (ORIF), and 25% had revision surgery. The total cost was €1,139,650.17. The average cost was €14,610.90. Significantly higher costs were incurred for revision compared to ORIF treatments, admissions that lasted more than 30 days, and patients who required more than one operation during admission. The most costly factors were the hospital stay (46%), the cost of the surgery itself (35%), and the implants (24%). Conclusions: Revision arthroplasty versus ORIF treatment, admissions lasting more than 30 days, and patients requiring more than one operation on admission incurred significantly higher costs. The average cost, from a hospital perspective, generated by a PPHF was €14,610.90. The most costly factors were, in descending order, the hospital stay, the cost of the surgery itself, and the implants. It is necessary to establish protocols and updated therapeutic algorithms in the perioperative management of PPHF in order to reduce both morbidity rates and associated costs.(AU)

Introducción: La artroplastia de cadera es una de las operaciones con mejores resultados en cirugía ortopédica. Las fracturas periprotésicas de cadera (FPPC) tienen consecuencias muy graves para el paciente y además suponen un impacto económico muy importante para los sistemas sanitarios. El objetivo del estudio es realizar el primer análisis detallado de los costes de las FPPC en un Servicio de Cirugía Ortopédica y Traumatología en un hospital universitario de tercer nivel en España. Métodos: El estudio incluyó a todos los pacientes ingresados entre 2009 y 2019 con el diagnóstico de «FPPC». Se evaluaron el coste de la estancia hospitalaria, el coste total del quirófano, el coste de los implantes utilizados, los análisis de sangre, las consultas con otros especialistas, las sesiones de rehabilitación, las pruebas radiológicas, la microbiología, las transfusiones de sangre y otras intervenciones quirúrgicas durante el mismo ingreso. Resultados: Se incluyó a un total de 78 pacientes, 49 mujeres y 29 hombres, con una edad media de 78,74 años (R 45-92); 69 pacientes recibieron tratamiento quirúrgico, el 75% se sometió a reducción abierta y fijación interna (RAFI) y el 25% a revisión protésica. El coste total fue de 1.139.650,17 €. El coste medio fue de 14.610,90 €. Los costes fueron significativamente más elevados en la revisión protésica que en la RAFI, en los ingresos que duraron más de 30 días y en los pacientes que requirieron más de una intervención quirúrgica durante el ingreso. Los factores que más influyeron en el coste fueron la estancia hospitalaria (46%), el coste de la intervención quirúrgica (35%) y el de los implantes (24%). Conclusiones: La cirugía de revisión protésica frente a RAFI, los ingresos de más de 30 días y los pacientes que requirieron más de una intervención quirúrgica durante el ingreso supusieron costes significativamente mayores. El coste medio, desde el punto de vista hospitalario, generado por una FPPC fue de 14.610,90 €.(AU)

Impacto económico de la COVID-19 en el sector de la salud en Santiago de Cuba / Economic impact of COVID-19 in the health sector of Santiago de Cuba

Introducción: El enfrentamiento a la epidemia de la COVID-19 tuvo un impacto económico negativo en el mundo, lo que generó un incremento de los gastos y costos en el sector de la salud en la provincia de Santiago de Cuba. Objetivo: Describir el impacto económico de la COVID-19 en el sector sanitario en Santiago de Cuba durante un año. Métodos: Se realizó un estudio descriptivo y prospectivo en la provincia de Santiago de Cuba en el año 2021, para lo cual se analizaron las variables días-pacientes, gastos presupuestarios, salario promedio del personal, costos totales de un día-paciente y costos unitarios de un día-paciente. Resultados: La investigación reveló un incremento en los gastos y su efecto en la economía del sector sanitario en el 2021. Al analizar los gastos por partidas, se determinó una mayor significación en los de medicamentos, con 59,0 % del total, lo que representó un crecimiento de los costos unitarios en comparación con los estándares publicados. Conclusiones: Los gastos del sector sanitario en esta provincia contribuyeron a controlar la propagación de la COVID-19, a evitar el sobregasto por la introducción de las vacunas, y permitieron la disminución de los índices de infección. Además, se evidenció el incremento de los costos en los diferentes niveles de actividad entre 3 y 29 veces más que los costos estandarizados del país.

Introduction: The confrontation to the epidemic of COVID-19 had a negative economic impact in the world, what generated an increment of the expenses and costs in the health sector of Santiago de Cuba province. Objective: To describe the economic impact of the COVID-19 in the sanitary sector of Santiago de Cuba during a year. Methods: A descriptive and prospective study was carried out in Santiago de Cuba province in the year 2021, for which the day-patient, budgetary expenses, average salary, total costs of a day-patient and unitary costs of a day-patient variables were analyzed. Results: The investigation revealed an increment in the expenses and its effect in the economy of the sanitary sector in 2021. When analyzing the expenses for departures, a higher significance was determined in those of medications, with 59.0 % of the total, what represented a growth of the unitary costs in comparison with the published standards. Conclusions: The expenses of the sanitary sector in this province contributed to control the propagation of COVID-19, to avoid the over expense for the introduction of vaccines, and allowed the decrease of the infection indexes. Also, the increment of the costs was evidenced in the different activity levels between 3 and 29 times more than the standardized costs of the country.

Impacto económico de la falla cardíaca en el cuidador informal / Economic impact of heart failure in the informal caregiver

Resumen Introducción: La insuficiencia cardíaca (IC) es una patología estructural o funcional del corazón que deteriora la capacidad de llenado, generando síntomas que afectan la calidad de vida y la funcionalidad. Es conocido el impacto de esta enfermedad sobre los sujetos que la padecen, pero ha sido poco explorado su impacto económico sobre los cuidadores. Objetivo: Estimar el impacto económico de la IC desde la perspectiva de los cuidadores informales. Resultados: Estudio cuantitativo, tipo evaluación económica parcial. Fueron incluidos 54 sujetos diagnosticados con IC y un cuidador informal por sujeto. La edad promedio de los sujetos con IC fue 70.61 años, la mayoría hombres (64.8%), con un tiempo de diagnóstico de 84 meses y un puntaje de Barthel de 81.94, que representa una dependencia leve. Respecto a los cuidadores, el 48.1% reportaban un vínculo laboral activo; el ingreso mediano fue de $1260.000 COP/mes. El número de horas de cuidado fue de 4.93 h/día. El impacto económico se reflejó en los ingresos mensuales, causando una pérdida de $644,017.50 por actividades de cuidado y en el tiempo laboral una reducción del 30%. El 29% de los ingresos fueron destinados a labores del cuidado; por lo tanto, generaron gastos que redujeron el 71% de los ingresos. De acuerdo con lo anterior, por cada 10 horas de trabajo se destinan 7 horas al cuidado. Conclusiones: La IC impacta de manera negativa la economía de los cuidadores informales de sujetos con esta patología.

Abstract Introduction: Heart failure (HF) is a structural or functional pathology of the heart that impairs filling capacity of this organ, generating symptoms that affect quality of life and functionality in subjects who suffer this disease. This impact on economic life in caregivers of patients with HF has been poorly studied, therefore, there is a lack of information about this topic. Objective: To estimate the economic impact of HF from the perspective of informal caregivers. Type of study: quantitative study, partial economic evaluation type. Population and sample: 54 subjects diagnosed with HF and one informal caregiver per subject were included. Results: The average age of the subjects with HF is 70.61 years, most of them men (64.8%), with a diagnosis time of 84 months and a Barthel score of 81.94 points, which represents a mild dependency. Regarding caregivers, 48.1% reported an active employment relationship, the median income was $1,260,000 COP/month. The number of hours of care is 4.93 hours/day. The economic impact was reflected in monthly income, causing a loss of $644,017.50 due to care activities and a 30% reduction in working time. 29% of income was allocated to care work, therefore, they generated expenses that reduced 71% of income. According to the above, for every 10 hours of work, 7 hours are spent on care. Conclusions: HF negatively impacts the economy of the informal caregiver of subjects with this pathology.

Factors associated to the market value of professional soccer players / Factores asociados al valor de mercado de los futbolistas profesionales / Fatores associados ao valor de mercado de jogadores profissionais de futebol

The objective of this study was analysed to the market value (MV) of professional soccer players from Top-5 European Soccer Leagues. An ANOVA analysed the effect of the independent variables on the MV of the soccer players, with p<0.01. Soccer players from the Premier League (PL) showed greater MV compared to other leagues. Foreign soccer players showed greater MV compared to national soccer players. Soccer players between 21-30 years showed greater MV compared to those <21 and >30 years. Forward and midfielders showed greater MV compared to goalkeepers and backs. Soccer players that represented their countries at international matches showed greater MV compared to those that did not. The soccer players with a youth background formation in their clubs in the Premier League and La Liga showed greater MV compared to soccer players coming from other clubs. In conclusion, extrinsic factors affect the MV of soccer players. Research results may be useful to the sport managers in the selection of professional soccer players. (AU)

El objetivo de este estudio fue analizar el valor de mercado (VM) de futbolistas profesionales de las 5 mejores ligas europeas de fútbol. Se analizó el efecto de las variables independientes sobre el VM de los futbolistas, mediante una ANOVA con un nivel de significación de p <0.01. Los futbolistas de la Premier League (PL) mostraron mayor VM en comparación con los de otras ligas. Los futbolistas extranjeros mostraron mayor VM en comparación con los futbolistas nacionales. Los futbolistas entre 21-30 años mostraron mayor VM en comparación con los <21 y > 30 años. Los delanteros y centrocampistas, mostraron mayor VM en comparación con los porteros y los laterales. Los futbolistas que representaron a sus países en partidos internacionales mostraron mayor VM en comparación con los que no lo hicieron. Los futbolistas de formación juvenil en clubes de la PL y La Liga (LL) mostraron mayor VM en comparación con los futbolistas de otros clubes. En conclusión, factores intrínsecos y extrínsecos afectan el VM de los futbolistas. Los resultados de esta investigación pueden ser útiles para los directores deportivos en el proceso de selección de futbolistas profesionales. (AU)

O objetivo deste estudo foi analisar o valor de mercado (VM) de jogadores de futebol profissional das 5 melhores ligas europeias de futebol. O efeito das variáveis independentes sobre a VM dos futebolistas foi analisado por meio de uma ANOVA com nível de significância de p <0,01. Os jogadores de futebol da Premier League (PL) apresentaram MV mais alto em comparação com os de outras ligas. Os jogadores de futebol estrangeiros apresentaram VM superior em comparação aos jogadores de futebol nacionais. Jogadores de futebol entre 21-30 anos apresentaram maior VM em comparação com aqueles com <21 e> 30 anos. Os atacantes e meio-campistas mostraram maior VM em relação aos goleiros e laterais. Os jogadores de futebol que representaram seus países em jogos internacionais apresentaram maior MV em comparação com aqueles que não o fizeram. Jogadores de futebol em formação de jovens em clubes da PL e La Liga (LL) apresentaram maior VM em comparação com jogadores de futebol de outros clubes. Em conclusão, fatores intrínsecos e extrínsecos afetam a VM dos jogadores de futebol. Os resultados desta pesquisa podem ser úteis para dirigentes esportivos no processo de seleção de jogadores profissionais de futebol. (AU)

Economic impact of periprosthetic hip fractures. / [Artículo traducido] Impacto económico de las fracturas periprotésicas de cadera.

INTRODUCTION: Hip replacement is one of the most successful operations in orthopaedic surgery. Periprosthetic hip fractures (PPHF) have very serious consequences for the patient, and they also entail a very important economic impact on healthcare systems. The aim of the study was to provide the first detailed cost analysis of PPHF in a traumatology and orthopaedics service in a third level hospital in Spain. METHODS: The study included all patients admitted between 2009 and 2019 with a diagnosis of «PPHF¼. We assessed hospital stay cost, total cost of the operating theatre, cost of the implants used, analyses, consultations with other specialists, rehabilitation sessions, radiological tests, microbiology, blood transfusions and other surgical operations during the same admission. RESULTS: Seventy-eight patients were included in the study, 49 women and 29 men, with a mean age of 78.74 years (R 45-92). Sixty-nine patients received surgical treatment, 75% had open reduction and internal fixation (ORIF), and 25% had revision surgery. The total cost was €1 139 650.17. The average cost was €14 610.90. Significantly higher costs were incurred for revision compared to ORIF treatments, admissions that lasted more than 30 days, and patients who required more than one operation during admission. The most costly factors were the hospital stay (46%), the cost of the surgery itself (35%), and the implants (24%). CONCLUSIONS: Revision arthroplasty versus ORIF treatment, admissions lasting more than 30 days, and patients requiring more than one operation on admission incurred significantly higher costs. The average cost, from a hospital perspective, generated by a PPHF was €14 610.90. The most costly factors were, in descending order, the hospital stay, the cost of the surgery itself, and the implants. It is necessary to establish protocols and updated therapeutic algorithms in the perioperative management of PPHF in order to reduce both morbidity rates and associated costs.

Impacto económico del tratamiento a largo plazo de la incontinencia fecal grave / Economic burden of long-term treatment of severe fecal incontinence

Objetivo Conocer el coste económico a largo plazo asociado al tratamiento de la incontinencia fecal grave mediante SNS frente al tratamiento conservador sintomático y la colostomía definitiva. Métodos Estudio descriptivo pormenorizado de los costes del proceso asistencial (intervenciones, consultas, dispositivos, pruebas complementarias, hospitalización, etc.) de 3 alternativas de tratamiento de la incontinencia fecal empleando herramientas de gestión y contabilidad analítica del propio Servicio de Salud con base en datos de actividad clínica. Se estimó, en cada caso, la frecuencia de uso de recursos sanitarios o la cantidad de productos dispensados en farmacias (medicación, pañales, material de ostomía, etc.). Se incluyeron costes derivados de situaciones adversas. Se incluyeron pacientes con incontinencia fecal grave, definida por una puntación superior a 9 en la escala de severidad de Wexner, en los que han fracasado los tratamientos de primera línea. Se emplearon datos de una cohorte consecutiva de 93 pacientes a los que se realizó una SNS entre los años 2002 y 2016; de pacientes intervenidos de colostomía definitiva (n=2); hernia paraestomal (n=3) y estenosis de colostomía (n=1). Resultados El coste medio acumulado en 10 años por paciente en cada alternativa fue: 10.972,9€ para el tratamiento sintomático (62% pañales); 17.351,57€ para la SNS (95,83% intervenciones; 81,6% dispositivos), y 25.858,54€ para la colostomía definitiva (70,4% material de ostomía) Conclusiones El manejo de la incontinencia fecal grave implica un gran impacto en términos económicos. La colostomía es la alternativa que más costes directos genera, seguida de la SNS y el tratamiento sintomático (AU)

Introduction Find out the long-term economic cost associated with the treatment of severe fecal incontinence by SNS versus symptomatic conservative treatment and definitive colostomy. Methods Detailed descriptive study of the costs of the healthcare process (interventions, consultations, devices, complementary tests, hospitalization, etc.) of 3 treatment alternatives for fecal incontinence using analytical accounting tools of the Health Service based on clinical activity data. The frequency of use of health resources or the quantity of products dispensed in pharmacies (medication, diapers, ostomy material, etc.) was estimated in each case. Costs derived from adverse situations were included. Patients with severe fecal incontinence, defined by a score greater than 9 on the Wexner severity scale, in whom first-line treatments had failed, were included. Data from a consecutive cohort of 93 patients who underwent an SNS between 2002 and 2016 were used; patients who underwent definitive colostomy (n=2); parastomal hernia (n=3), and colostomy stenosis (n=1). Results The mean cumulative cost in 10 years per patient in each alternative was: € 10,972.9 symptomatic treatment (62% diapers); € 17,351.57 SNS (95.83% interventions; 81.6% devices); € 25,858.54 definitive colostomy (70.4% ostomy material and accessories). Conclusions Management of severe fecal incontinence implies a great burden in economic terms. The colostomy is the alternative that generates the most direct cost, followed by SNS and symptomatic treatment (AU)

Economic burden of long-term treatment of severe fecal incontinence.

INTRODUCTION: Find out the long-term economic cost associated with the treatment of severe fecal incontinence by SNS versus symptomatic conservative treatment and definitive colostomy. METHODS: Detailed descriptive study of the costs of the healthcare process (interventions, consultations, devices, complementary tests, hospitalization, etc.) of 3 treatment alternatives for fecal incontinence using analytical accounting tools of the Health Service based on clinical activity data. The frequency of use of health resources or the quantity of products dispensed in pharmacies (medication, diapers, ostomy material, etc.) was estimated in each case. Costs derived from adverse situations were included. Patients with severe fecal incontinence, defined by a score greater than 9 on the Wexner severity scale, in whom first-line treatments had failed, were included. Data from a consecutive cohort of 93 patients who underwent an SNS between 2002 and 2016 were used; patients who underwent definitive colostomy (n=2); parastomal hernia (n=3); and colostomy stenosis (n=1). RESULTS: The mean cumulative cost in 10 years per patient in each alternative was: € 10,972.9 symptomatic treatment (62% diapers); € 17,351.57 SNS (95.83% interventions; 81.6% devices); € 25,858.54 definitive colostomy (70.4% ostomy material and accessories). CONCLUSIONS: Management of severe fecal incontinence implies a great burden in economic terms. The colostomy is the alternative that generates the most direct cost, followed by SNS and symptomatic treatment.

Economic impact of periprosthetic hip fractures.

INTRODUCTION: Hip replacement is one of the most successful operations in orthopaedic surgery. Periprosthetic hip fractures (PPHF) have very serious consequences for the patient, and they also entail a very important economic impact on healthcare systems. The aim of the study was to provide the first detailed cost analysis of PPHF in a traumatology and orthopaedics service in a third level hospital in Spain. METHODS: The study included all patients admitted between 2009 and 2019 with a diagnosis of "PPHF". We assessed hospital stay cost, total cost of the operating theatre, cost of the implants used, analyses, consultations with other specialists, rehabilitation sessions, radiological tests, microbiology, blood transfusions and other surgical operations during the same admission. RESULTS: 78 patients were included in the study, 49 women and 29 men, with a mean age of 78.74 years (R 45-92). 69 patients received surgical treatment, 75% had open reduction and internal fixation (ORIF), and 25% had revision surgery. The total cost was €1,139,650.17. The average cost was €14,610.90. Significantly higher costs were incurred for revision compared to ORIF treatments, admissions that lasted more than 30 days, and patients who required more than one operation during admission. The most costly factors were the hospital stay (46%), the cost of the surgery itself (35%), and the implants (24%). CONCLUSIONS: Revision arthroplasty versus ORIF treatment, admissions lasting more than 30 days, and patients requiring more than one operation on admission incurred significantly higher costs. The average cost, from a hospital perspective, generated by a PPHF was €14,610.90. The most costly factors were, in descending order, the hospital stay, the cost of the surgery itself, and the implants. It is necessary to establish protocols and updated therapeutic algorithms in the perioperative management of PPHF in order to reduce both morbidity rates and associated costs.

E-scooter accidents: A new epidemic. / Accidentes en patinete eléctrico: una nueva epidemia.

INTRODUCTION: During the last years, the use of e-scooter has become more and more popular due to the versatility as the practicality in intra-urban mobility. However, e-scooter has turned into a spring of accidents, lot of them, severe, causing new public health problems and significantly increasing the direct and indirect healthcare costs. OBJECTIVE: To characterize the epidemiology of the injuries caused by e-scooter related accidents and to study their indirect economic impact in work-related accidents hospital. MATERIALS AND METHODS: Retrospective and descriptive study in which has been checked all the medical information about the patients attended in the ER (emergency room) of the Hospital Asepeyo Sant Cugat, who suffered e-scooter accident from January 2018 to December 2020. RESULTS: 167 patients were included in the study. 55% (92) were male and 45% (75) were female. The average of age was 37.4 years-old. There were quantified 117 different fractures in 105 patients (63%). Other injuries documented were: 36 patients with multiple contusions, 16 head traumas and 4 wounds which required suture. The most frequent ligamentous injuries were 4 ACL ruptures, 3 ACJ dislocations and 2 patients with rupture of the UCL of the thumb. 105 patients required hospital admission, 3 of them in ICU. The 51% of the cases required surgical treatment of their injuries. In that period, as a consequence of the work inabilities generated by the total of the patients included in the study, the added cost for the hospital was around 1,062,444€. CONCLUSIONS: The popularization of e-scooters between the employed population has caused a high increased number of accidents in this range of age. Most of the injuries observed may be compared with those seen in high-energy traumas. These cause an important socio-economic impact due to the nature of the injuries and the potential complications that could appear. The work inabilities observed as a consequence of e-scooter related injuries in the employed population have caused a substantial economic impact, shooting up to more than 1,000,000€ the indirect cost of our hospital during the reviewed period.

Accidentes en patinete eléctrico: una nueva epidemia / E-scooter accidents: A new epidemic

Introducción: El uso de patinetes eléctricos se ha popularizado como medio de transporte en los últimos años, tanto por su versatilidad como por la practicidad en el uso de estos. Sin embargo, no dejan de ser una fuente de accidentes, muchas veces graves, generando nuevos problemas de salud pública y aumentando los costes de esta. Objetivo: Caracterizar la epidemiología de las lesiones producidas por accidentes en patinete eléctrico y estudiar el impacto económico indirecto en una mutua laboral. Materiales y métodos: Estudio descriptivo, donde se revisan retrospectivamente los pacientes atendidos en urgencias, del Hospital de Asepeyo en Sant Cugat, que han sufrido accidentes en patinete eléctrico en el periodo comprendido entre enero de 2018 y diciembre de 2020. Resultados: Se incluyeron 167 pacientes. El 55% (92) de los pacientes fueron hombres y el 45% (75) mujeres, con una edad media de 37,4 años. Se diagnosticaron 117 fracturas en el 63% (105) de los pacientes. Otras lesiones frecuentes documentadas fueron: 36 policontusiones, 16 TCE y 4 heridas que requirieron sutura. Las lesiones ligamentosas más comúnmente observadas fueron: 4 casos de rotura aguda de LCA, 3 casos de luxación acromioclavicular y 2 casos de rotura del LCC del pulgar. Un total de 105 pacientes requirieron ingreso hospitalario, 3 de ellos en UCI. El 51% (85) de los pacientes requirieron tratamiento quirúrgico. Durante ese periodo, el coste generado como consecuencia de las bajas laborales ascendió a 1.062.444€. Conclusiones: El patinete eléctrico está comportando un incremento significativo de accidentes de tráfico en población adulta joven. Las lesiones que provocan pueden compararse con las vistas en accidentes de alta energía, generando un alto impacto socioeconómico debido a la naturaleza de las lesiones y sus potenciales complicaciones.(AU)

Introduction: During the last years, the use of e-scooter has become more and more popular due to the versatility as the practicality in intra-urban mobility. However, e-scooter has turned into a spring of accidents, lot of them, severe, causing new public health problems and significantly increasing the direct and indirect healthcare costs. Objective: To characterize the epidemiology of the injuries caused by e-scooter related accidents and to study their indirect economic impact in work-related accidents hospital. Materials and methods: Retrospective and descriptive study in which has been checked all the medical information about the patients attended in the ER (emergency room) of the Hospital Asepeyo Sant Cugat, who suffered e-scooter accident from January 2018 to December 2020. Results: 167 patients were included in the study. 55% (92) were male and 45% (75) were female. The average of age was 37.4 years-old. There were quantified 117 different fractures in 105 patients (63%). Other injuries documented were: 36 patients with multiple contusions, 16 head traumas and 4 wounds which required suture. The most frequent ligamentous injuries were 4 ACL ruptures, 3 ACJ dislocations and 2 patients with rupture of the UCL of the thumb. 105 patients required hospital admission, 3 of them in ICU. The 51% of the cases required surgical treatment of their injuries. In that period, as a consequence of the work inabilities generated by the total of the patients included in the study, the added cost for the hospital was around 1,062,444€. Conclusions: The popularization of e-scooters between the employed population has caused a high increased number of accidents in this range of age. Most of the injuries observed may be compared with those seen in high-energy traumas. These cause an important socio-economic impact due to the nature of the injuries and the potential complications that could appear.(AU)

E-scooter accidents: A new epidemic / Accidentes en patinete eléctrico: una nueva epidemia

Introduction: During the last years, the use of e-scooter has become more and more popular due to the versatility as the practicality in intra-urban mobility. However, e-scooter has turned into a spring of accidents, lot of them, severe, causing new public health problems and significantly increasing the direct and indirect healthcare costs. Objective: To characterize the epidemiology of the injuries caused by e-scooter related accidents and to study their indirect economic impact in work-related accidents hospital. Materials and methods: Retrospective and descriptive study in which has been checked all the medical information about the patients attended in the ER (emergency room) of the Hospital Asepeyo Sant Cugat, who suffered e-scooter accident from January 2018 to December 2020. Results: 167 patients were included in the study. 55% (92) were male and 45% (75) were female. The average of age was 37.4 years-old. There were quantified 117 different fractures in 105 patients (63%). Other injuries documented were: 36 patients with multiple contusions, 16 head traumas and 4 wounds which required suture. The most frequent ligamentous injuries were 4 ACL ruptures, 3 ACJ dislocations and 2 patients with rupture of the UCL of the thumb. 105 patients required hospital admission, 3 of them in ICU. The 51% of the cases required surgical treatment of their injuries. In that period, as a consequence of the work inabilities generated by the total of the patients included in the study, the added cost for the hospital was around 1,062,444€. Conclusions: The popularization of e-scooters between the employed population has caused a high increased number of accidents in this range of age. Most of the injuries observed may be compared with those seen in high-energy traumas. These cause an important socio-economic impact due to the nature of the injuries and the potential complications that could appear.(AU)

Introducción: El uso de patinetes eléctricos se ha popularizado como medio de transporte en los últimos años, tanto por su versatilidad como por la practicidad en el uso de estos. Sin embargo, no dejan de ser una fuente de accidentes, muchas veces graves, generando nuevos problemas de salud pública y aumentando los costes de esta. Objetivo: Caracterizar la epidemiología de las lesiones producidas por accidentes en patinete eléctrico y estudiar el impacto económico indirecto en una mutua laboral. Materiales y métodos: Estudio descriptivo, donde se revisan retrospectivamente los pacientes atendidos en urgencias, del Hospital de Asepeyo en Sant Cugat, que han sufrido accidentes en patinete eléctrico en el periodo comprendido entre enero de 2018 y diciembre de 2020. Resultados: Se incluyeron 167 pacientes. El 55% (92) de los pacientes fueron hombres y el 45% (75) mujeres, con una edad media de 37,4 años. Se diagnosticaron 117 fracturas en el 63% (105) de los pacientes. Otras lesiones frecuentes documentadas fueron: 36 policontusiones, 16 TCE y 4 heridas que requirieron sutura. Las lesiones ligamentosas más comúnmente observadas fueron: 4 casos de rotura aguda de LCA, 3 casos de luxación acromioclavicular y 2 casos de rotura del LCC del pulgar. Un total de 105 pacientes requirieron ingreso hospitalario, 3 de ellos en UCI. El 51% (85) de los pacientes requirieron tratamiento quirúrgico. Durante ese periodo, el coste generado como consecuencia de las bajas laborales ascendió a 1.062.444€. Conclusiones: El patinete eléctrico está comportando un incremento significativo de accidentes de tráfico en población adulta joven. Las lesiones que provocan pueden compararse con las vistas en accidentes de alta energía, generando un alto impacto socioeconómico debido a la naturaleza de las lesiones y sus potenciales complicaciones.(AU)